Keywords: Cipla, DNDI, Pediatric antiretrovirals, IV, AIDS

DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination

Article | 24 July 2012

Coinciding with the XIX International AIDS Conference in Washington DC, the Drugs for Neglected Diseases initiative (DNDi), a not-for-profit R& ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Cipla

Go to company listing